- Home
- MOS vs RGEN Comparison
MOS vs RGEN Comparison
Compare MOS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOS
- RGEN
- Stock Information
- Founded
- MOS 2004
- RGEN 1981
- Country
- MOS United States
- RGEN United States
- Employees
- MOS N/A
- RGEN N/A
- Industry
- MOS Agricultural Chemicals
- RGEN Medical/Dental Instruments
- Sector
- MOS Industrials
- RGEN Health Care
- Exchange
- MOS Nasdaq
- RGEN Nasdaq
- Market Cap
- MOS 8.9B
- RGEN 8.2B
- IPO Year
- MOS 2004
- RGEN N/A
- Fundamental
- Price
- MOS $25.68
- RGEN $142.85
- Analyst Decision
- MOS Hold
- RGEN Buy
- Analyst Count
- MOS 11
- RGEN 10
- Target Price
- MOS $34.40
- RGEN $188.38
- AVG Volume (30 Days)
- MOS 3.5M
- RGEN 815.6K
- Earning Date
- MOS 11-05-2024
- RGEN 10-29-2024
- Dividend Yield
- MOS 3.15%
- RGEN N/A
- EPS Growth
- MOS N/A
- RGEN N/A
- EPS
- MOS 0.75
- RGEN N/A
- Revenue
- MOS $12,193,800,000.00
- RGEN $602,354,000.00
- Revenue This Year
- MOS N/A
- RGEN $0.08
- Revenue Next Year
- MOS $1.77
- RGEN $12.97
- P/E Ratio
- MOS $35.48
- RGEN N/A
- Revenue Growth
- MOS N/A
- RGEN N/A
- 52 Week Low
- MOS $24.12
- RGEN $110.45
- 52 Week High
- MOS $38.30
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- MOS 46.92
- RGEN 48.03
- Support Level
- MOS $25.06
- RGEN $135.88
- Resistance Level
- MOS $27.00
- RGEN $150.84
- Average True Range (ATR)
- MOS 0.74
- RGEN 5.21
- MACD
- MOS 0.07
- RGEN -0.14
- Stochastic Oscillator
- MOS 52.88
- RGEN 52.51
About MOS Mosaic Company (The)
Formed in 2004 by the combination of IMC Global and Cargill's fertilizer business, Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosiac Fertilizantes business, which the company acquired from Vale in 2018.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.